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Plexin (PLXN) receptors, and their ligands, semaphorins (SEMAs), traditionally mediate 
axon growth in the visual system by facilitating actin cytoskeletal rearrangements and initiating 
growth cone collapse through intracellular signaling mechanisms. A proposed novel mechanism 
for the development of the early eye involves the interaction of SEMA6A and PLXNA2 to direct 
migration and proliferation of retinal precursor cells (Ebert et al., 2014). However, this model is 
not fully explained by previous data; we propose that a related PLXNA family member, 
PLXNA1a, also plays a role in these processes. This research uses in situ hybridization and 
antisense morpholino gene knockdown to identify the expression and preliminary functional role 
of the uncharacterized PLXNA1a receptor in early zebrafish eye development. We hypothesize 








Chapter 1: Introduction 
 
During formation of the eye, neural plate cells evaginate bilaterally from the neural tissue 
that will become the brain to form the optic cup and optic stalk. Retinal progenitor cells continue 
to migrate into the optic cup from the optic stalk during development and will eventually become 
the neuronal cells that create the laminar structure of the retina (Figure 1) (Gestri et al., 2012; Ali 
& Sowden, 2011). These progenitor cells are guided to the proper destination within the eye by a 
multitude of guidance guides. Recently, it was discovered that signaling between SEMA6A and 
PLXNA2 is crucial for this migration process (Ebert et al., 2014). Proper guidance at this stage, 
as well as later in development, is critical because it is the basis of the retinotopic organization of 
the visual system in vertebrates, which creates an accurate perception of the environment from 
visual stimuli. Adequate proliferation during these early stages of eye development ensures there 
are enough retinal progenitors to generate the entire eye structure. 
Plexins are single transmembrane-spanning receptors; their primary ligands are 
semaphorins, which are secreted or transmembrane glycoproteins that regulate cell motility 
(Janssen et al., 2010). 9 different plexins have been identified in vertebrates and categorized into 
4 classes (A- D) and 8 classes of semaphorins (semas) have been described (1 being viral) 
(Waimey & Cheng, 2006; Krueger, Aurandt, & Guan, 2005). These molecules interact as 
homodimers within a sema binding domain on both proteins (Janssen et al., 2010) (Figure 2). 
PLXNA1 typically is associated with SEMA3A, 3F, and 6D and PLXNA2 has been associated 
with SEMA3A however there is a large variability in binding across tissue types and 
developmental stages (Figure 2) (Murakami et al., 2001).  





Figure 1: Early eye development in vertebrates. (A) Optic vesicles evaginate from the diencephalon towards 
the surface ectoderm. (B) Optic vesicles invaginate forming the optic cup and pull in epithelium to form the 
primitive lens. (C) The developed eye consists of a laminated neural retina containing all neurons and glia, 
retinal pigmented epithelium (RPE), and lens. Republished with permission (License #: 3621911069173). 
http://www.nature.com/nature/journal/v472/n7341/full/4720
42a.html 





Figure 2. Schematic of the domain structures of semaphorin ligands and plexin 
receptors and their identified interactions. Republished with permission (License #: 
3621911205125). 




Both semas and plexins are expressed in the developing nervous system in high 
abundance but their expression is quite low in adult tissues, with the exception of the 
hippocampus. There is evidence however that they may be involved in regeneration after trauma 
(Hota & Buck, 2012). Semaphorins traditionally act as repulsive cues in the environment that 
direct axon growth in the developing nervous system by activating intracellular signaling 
mechanisms via its interaction with a plexin receptor. The result of this interaction is alteration of 
the stability of the actin cytoskeleton and initiation of growth cone collapse (Negishi et al., 
2005). Activation of Rho-family small GTPases is responsible for this remodeling (Hota & 
Buck, 2012). Additionally, cell adhesion molecules (CAMs) are often part of this cascade and 
mediate adhesion and proliferation (Waimey & Cheng, 2006).   
Preliminary research from the Ebert lab has shown that plexinA2 is present in the early 
eye vesicle and is interacting with SEMA6A in a novel tissue autonomous manner. Specifically, 
mRNA for the plexinA2 receptor is expressed in the ventral eye and the surrounding head 
mesenchyme during early stages of development (Figure 3) (Ebert et al., 2014). The presence of 
plexinA2 in this region is acting with sema6A as a ventral repellent mechanism to guide retinal 
progenitors. 
The result of this interaction is direction of migrating progenitors and promotion of eye 
vesicle cohesion. The downstream signaling mechanisms of this interaction may or may not be 
the same as the classical plexin/semaphorin pathway described above. PlexinA2 antisense 
morpholino knockdown resulted in decreases in proliferation of retinal precursor cells causing 
smaller eyes and a loss of cohesion of the retinal precursor cells within the eye field (Figure 4). 
This phenotype is copied by knockdown of SEMA6a, the receptor for PLXNA2. This data led to  
 










Figure 3. (A-D) RNA in situ hybridization for plexinA2 viewed in lateral wholemounts (A,B) 
and in sagittal (C) and transverse (D) sections. At 4-12 somites, plexinA2 mRNA is in the 
ventral, but not dorsal, eye (e) vesicle (outlined in white), as well as in the mesenchyme (m), 
somites (s) and brain (br). op, olfactory placode. Red dotted line separates the eye vesicle into 
approximate dorsal and ventral domains. Ebert et al., 2014. 










Figure 4. Antisense MO knockdown of plexinA2 and sema6A. (L, M) Rx3:GFP expression indicates 
retinal precursor cells outside the eye field in morphant embryos. (L’, M’) pHH3 
immunohistochemistry labeling demonstrates fewer proliferating cells within the GFP positive eye 
field in morphants. Quantification of (A) decrease in proliferation and (B) decrease in eye size in 
sema6A and plexinA2 morphants at 72 hpf. Ebert lab, unpublished data. 
B 
A 




the current model which is that retinal progenitor migration into the ventral eye is directed by 
SEMA6a repulsion with PLXNA2 and cells that enter the incorrect domain are removed from the 
eye field (Ebert et al., 2014). In addition, this signaling mechanism is involved in maintenance of 
proper levels of proliferation in the migrating eye field. However, this model is not fully 
explained simply by the interaction between PLXNA2 and SEMA6a alone and other plexin 
receptors may also be involved. For example, a dorsal directionality cue in the eye vesicle has 
yet to be identified. 
 Semas and plexins are abundantly expressed in the developing vertebrate visual system 
and are highly involved in maintenance of correct neuronal development. Another member of the 
plexin A family, plexinA1, is expressed in the medial periphery of the neural retina of mice at the 
site of ganglion cell accumulation (Murakami et al., 2001). Additionally, SEMA3A, which can 
bind PLXNA1, is found along the pathway of migrating retinal ganglion cells (RGCs) in mice 
and at their target during early development (30-60 hours post fertilization (hpf)) and in the inner 
nuclear layer of the retina during late development (72 hpf) (Callander et al., 2007). The current 
state of the literature has very little to say about the PLXNA1 receptor in zebrafish, its 
expression patterns, or its functional role, and how it relates to PLXNA2. Additionally, although 
two subtypes of the PLXNA1 receptor, A1a and A1b have been identified, no expression and 
functional differences between the two have emerged from any study. 
As mentioned previously, plexinA2 has a very specific ventral early eye field expression 
pattern. Interestingly, both plexinA1a and plexinA1b mRNA are also expressed in similar or 
surrounding regions at similar levels, suggesting that there may be an interaction or relationship  
 
 




between these three receptors, in terms of functional activity (Figure 5B, C). Coexpression of 
these receptors in same domains as SEMA6A indicates that they may share this ligand partner. 
This project aims to investigate the role of both the PLXNA1a and PLXNA1b receptors in the 
early eye. Furthermore, we will speculate as to which semaphorin(s) PLXNA1a and PLXNA1b 
may be interacting with during the early stages of eye development. Interestingly, our 
preliminary data imply that the two zebrafish plexinA1 homologs share early expression patterns 
in some tissues, however, later in development, they have divergent expression patterns. The 
second phase of this project is an investigation into the role of PLXNA1a specifically as it relates 
to PLXNA2 in formation and integrity of the early eye. Preliminary in situ expression data show 
that this homolog has a strong expression in the early neuronal tissues and surrounding head 
mesenchyme. 
In light of the preliminary data collected, we hypothesize that plexinA1a and A1b will 
show similar early expression patterns to plexinA2 and will be expressed in the developing eye 
and surrounding mesenchyme.  Additionally, we hypothesize that the knockdown of plexinA1 
will result in a similar phenotype to that seen for knockdown of plexinA2, that being a loss of 
proliferation and cohesion in the early eye. Furthermore, we hypothesize that plexinA1 can 
partially compensate for the loss of plexinA2 in morphants.  
Danio rerio (zebrafish) are an ideal model organism in developmental research because 
the embryos are externally fertilized, fairly large, can be genetically manipulated, and are easily 
visualized due to their transparency. Additionally, they have an accelerated period of early 
development with all major organs patterned within three days. Juveniles reach sexual maturity 
at three months of age. Development of the visual system in zebrafish is important immediately  
 




Figure 5. Early expression of plexin A’s. in situ hybridization at 10 hours in (A, B, C) whole-
mount and (A’, B’, C’) transverse section of plexinA2, plexinA1a, and plexinA1b. mRNA 
expression is observed in the developing eye as well as in the head mesenchyme (arrow). 
Ebert lab unpublished data. 
B A 














after fertilization because eyesight will be a major way for the zebrafish to escape predation. A 
fully functioning visual system is intact within three days post fertilization (Gestri et.al, 2012).  
Zebrafish research is relevant to mammalian biology because there is high homology 
between the zebrafish and mammalian genomes. Furthermore, zebrafish and mammals share 
common mechanisms of development. However, experimental design must take into account that 
zebrafish underwent a chromosomal duplication during the course of their evolution (Woods et 
al., 2000). This means that it is necessary to confirm that the zebrafish genes we are working 
with are orthologous to mammalian genes, and that they play a similar role. 
Studies of the mechanisms of zebrafish eye development have important implications for 
the generation of therapy techniques for many human diseases of the eye. For example, 
micropthalmia is a condition that arises before birth and results in an abnormally small size of 
one or both eyeballs, which is usually accompanied by a significant loss of vision (Figure 6) 
(Genetics Home Reference, 2014). An understanding of the process by which the early eye is 
formed through guidance and cell proliferation is crucial to development of therapies that can 






















Figure 6. Example of unilateral micropthalmia in a young child. Republished with 
permission (License #: 3621920417501). 




Chapter 2: Materials and Methods 
 
ZEBRAFISH HUSBANDRY 
All procedures were approved by the University of Vermont Animal Care Committee (Protocol 
#12-055). Zebrafish embryos were developmentally staged as previously described (Kimmel et 
al., 1995). Embryos were treated with 0.0003% phenylthiourea (PTU) (Sigma) at 24 hpf to block 
pigmentation, fixed with 4% paraformaldehyde (PFA) in phosphate buffered saline with 0.1% 
tween (PBT) overnight, and stored in 100% methanol (MeOH) at -20⁰C or PBT at 4⁰C.   
SEQUENCING AND ALIGNMENTS 
mRNA and protein sequences were taken from the NCBI database (PLXNA2: XP_689780.5; 
PLXNA1a: NP_001103480.1;  PLXNA1b:XP_003201265.3). Alignments were completed using 
the ClustalW website (Kyoto University Bioinformatics Center) and the BLAST program 
(National Center for Biotechnology Information). Protein domains and structures were identified 
using Phosphosite (Cell Signaling Technologies).  
RNA ANTISENSE PROBES 
Primers were designed to create a DNA product of approximately 500-600 base pairs with a SP6 
RNA polymerase promoter sequence on the forward primer and a T7 RNA polymerase promoter 
sequence on the reverse primer (Table 1). The DNA products were amplified at annealing 
temperatures of 63°C for plexinA1a and 55°C for plexinA1b. PCR products were verified on a 
1% agarose gel and 5 uL of sodium acetate (CH₃COONa) was added along with two volumes of 
100% ethanol (EtOH) to precipitate overnight at -20⁰C. Digoxigenin labeled antisense RNA 
probes were generated from 1ug of the DNA product with T7 RNA polymerase using the DIG 




RNA labeling kit from Roche as per manufacturer’s protocol. Probes were stored in 
hybridization buffer at -20⁰C (Thisse & Thisse, 2008).  Control in situs were done with no 
addition of RNA probe.  
 Forward Primer Reverse Primer 
plexinA1a 5’ CTCAGCCGGAAAACACATGG 3’ 5’ GAACTTCACCTCCGGGTTTC 3’ 
plexinA1b 5’ GGGACGCTGCAGATCTACTC 3’ 5’ AGCTGTCATGATGAGCGATG 3’ 
plexinA2 5’ CTTTGAACCACTCAGCACCA 3’ 5’ CGTATTCCAGTCGACCCTGT 3’ 
Table 1. Primer sequences for plexinA1a, plexinA1b, and plexinA2 mRNA probes 
 
RNA IN SITU HYBRIDIZATION AND SECTIONING 
In situ protocol adapted from Thisse & Thisse (2008). Embryos were rehydrated in 100% PBT, 
permeabilized with proteinase K, and incubated with 1% RNA probe in hybridization buffer at 
70⁰C overnight. The following day, they were equilibrated in 2X saline-sodium citrate 
(SSC)(175.3g NaCl, 88.2g Na3Citrate mixed in 10L H2O), rehydrated in PBT, and incubated in 
1:1000 anti-DIG (Roche) for 2 hours at room temperature. Embryos were placed in NBT-BCIP 
(nitro blue tetrazolium, chloride-5-bromo-4-chloro-3-indolyl phosphate) (Thermo Scientific) to 
visualize probe binding. Embryos were treated with 100% EtOH to remove background staining 
and imaged in PBT at 50X with a dissecting scope. All in situ experiments were performed at 
least once with a minimum of 10 embryos per age. A no-probe experiment was performed as a 
control (Supplemental Data, Figure 2). 
MORPHOLINOS 
Antisense oligonucleotide morpholinos (Gene Tools) were designed to target an exon/intron 
boundary within the Ras/GAP domain of plexinA1a mRNA and the exon 2/intron 2 boundary of 




plexinA2 mRNA (Table 2). Morpholinos were injected into rx3:GFP (early eye fields marked 
with green fluorescent protein) transgenic embryos at the one cell stage. Optimal knockdown 
was achieved at 4.0 nanograms and 2.0 nanograms of the plexinA1a  and plexinA2 morpholino 
respectively. In the double knockdown experiment, MOs were injected independently at 0.8 
nanograms as well as together at the same doses. Control and morphant embryos were fixed 
overnight in PFA and stored in MeOH or PBT as previously described. Embryos were imaged at 
40X on a Nikon Eclipse confocal microscope to compare morphant and control embryos. Eye 
area was measured on images taken at 20X on an Olympus IX71 fluorescent microscope using 
the Spot software (Diagnostic Instruments, Inc.). Embryo death was quantified at 18 hpf as a 
percent of the total embryos collected. 
Table 2. Sites for antisense morpholino binding  
PHOSPHO-HISTONE H3 STAINING 
Control and morphant embryos were taken off PBT and immunostained with a 1:1000 serine-10 
phospho-histone H3 (pHH3) antibody (Cell Signaling Technologies) to detect proliferating cells. 
This antibody binds to condensed chromosomes during M phase of the cell cycle. Embryos were 
confocal imaged at 40X. Eye proliferation was assessed from whole mount fluorescent pictures 
by comparing the eye area with the amount of pHH3+ cells within the GFP+ eye field. 
 
 
Gene Target site 
plexinA1a 5’ ACCAGTCGTTTGCTACCGTACCTCC 3’ 
plexinA2 5’ AAAAGCGATGTCTTTCTCACCTTCC 3’ 





Target sites for mutation within each gene were identified using the CHOPCHOP website 
(https://chopchop.rc.fas.harvard.edu/). Targets were designed to be approximately 20 base pairs 
in length and end with “NGG”, which comprises the PAM sequence (Table 3). Total sequences 
include the target oligo which acts as a guide template. Primers were also designed with 
CHOPCHOP to be a minimum of 20 base pairs away from the target site and produce a PCR 
product of 100-160 base pairs for identification of correct oligos (Table 4). 
Table 3. Sites for targeted CRISPR mutation 
 Forward Primer Reverse Primer 
plexinA1a 5’ GTGGAGAAGGCTTTGACTCTGT 3’ 5’ CCCTAAACCAGTCGTTTGCTAC 3’ 
plexinA2 5’ CCTTTTCACCCTCCTACTGATC 3’ 5’ CCTTTTTCAGTCGTCCACTCTT 3’ 
sema6a 5’ATATGAAGCTGAGCTGTGCTGA 3’ 5’GTTATGACACTCGTCCTGCAAA 3’ 
Table 4. Primers for CRISPR verification 
Protocol to generate CRISPR/Cas9 guide RNAs was adapted from Gagnon and colleagues 
(2014). CRISPR target oligos were annealed to the constant oligo and the DNA was precipitated 
in EtOH overnight. Oligo constructs were run on a 2% agarose gel to determine that they were 
the desired size of 120 base pairs. RNA was synthesized from these DNA constructs using the 
Sp6 mMessage mMachine Kit (Ambion, Inc.) and again precipitated in sodium acetate and EtOH 
overnight.   
Gene Target site 
plexinA1a 5’ AGCGCTGAGCCTCCAGCGTG 3’ 
plexinA2 5’ GACATCAACCAGCCCCTTGG 3’ 
sema6a 5’ GACCTGGAAGTCCAGACAGG 3’ 




Chapter 3: Results 
 
Phylogenetics and sequencing of plexinA1a, plexinA1b, and plexinA2 
As mentioned previously, plexins are highly conserved molecules across vertebrate 
species, as demonstrated by a preliminary phylogenetic tree (Figure 7). The zebrafish plexinA 
family members that we are particularly interested in show high sequence homology. plexinA1a 
and plexinA1b are found in close proximity on chromosome 23 while plexinA2 is located on a 
different chromosome . This distance in the genome indicates that they may have a shared 
ancestral origin and could potentially be gene duplications within the zebrafish genome. At the 
protein level, PLXNA1a and PLXNA2 are 64% identical and 78% similar (Figure 8). This 
indicates that the protein products of these genes likely have similar structure and function.  
Additionally, the functional domains of the PLXNA2 and PLXNA1a receptors show the 
same or increased homology as compared to the full protein.  The sema domain where the 
receptor binds its specific semaphorin ligand and the Ras/GAP domain, which initiates 
downstream signaling cascades within the cell, are 54% and 81% identical respectively for these 
two plexins (Figure 9A & B). The similarity between the sema domains specifically of 
PLXNA1a and PLXNA2 suggests that they may be interacting with the same semaphorin partner 
in the early eye tissue (Figure 9A). Co-expression of both plexins along with SEMA6A in the 
same early neuronal regions may signal that this semaphorin has multiple binding partners that 
can interact and cause different or similar downstream signaling events (Ebert et al., 2014).  This 
is supported by the similarity between the Ras/GAP domains, which determine the intracellular 
binding partners of the receptor (Figure 9B). 




PLXNA1a also shares high homology with PLXNA1b (Figure 10). We were unable to 
use the entire protein sequence for PLXNA1b because the full genetic sequence was not 
available. Therefore, we aligned the proteins from the C-terminal end to investigate their 
similarity. Due to the close genomic proximity of these two homologs, it is likely that they are 
duplicated genes.  A full alignment of the current amino acid sequences for all three plexin 
receptors to compare domains and predicted phosphorylation sites and important residues was 
also performed (Supplemental Data, Figure 1).  





Figure 7. Phylogenetic tree of PLXNA1 across 10 vertebrate species. Top to bottom: 
chicken, frog, human, rhesus monkey, chimp, dog, mouse, rat, cow, and zebrafish. Zebrafish 
sequence used is PLXNA1a.  
 
Gallus gallus (chicken) 
Xenopus tropicalis (frog) 
Homo sapien (human) 
Macaca mulatta (rhesus monkey) 
Pan troglodyte (chimpanzee) 
Canis lupis familiaris (dog) 
Mus musculus (mouse) 
Rattus norvegicus (rat) 
Bos Taurus (cow) 
Danio rerio (zebrafish) 












Figure 8. PLXNA1a and PLXNA2 share high sequence homology. Partial c-terminus alignment of 
Danio rerio PLXNA1a (top) and PLXNA2 (bottom). At the amino acid level, the total sequences are 
64% identical and 78% similar. 
PLXNA1a 
PLXNA2 








Figure 9. Alignment of the functional domains of Danio rerio PLXNA1a (top) and PLXNA2 (bottom). 
At the amino acid level, the (A) sema domain sequences are 54% identical and 71% similar and the (B) 









Figure 10. Alignment of Danio rerio PLXNA1a (top) and PLXNA1b (bottom). At 
the amino acid level, sequences are 86% identical and 93% similar. 




 Expression profiles of plexinA1a and plexinA1b 
The first avenue of investigation we 
explored is the spatial and temporal mRNA 
expression patterns of the plexinA1a and 
plexinA1b receptors in the developing zebrafish 
embryo, specifically in the eye. This was 
accomplished by in situ hybridization to detect 
mRNA transcripts with complementary 
antisense probes that were amplified from 
primers designed to the gene sequence by PCR (Figure 11). Preliminary data have indicated 
whole-embryo expression patterns but more investigation was necessary to localize expression to 
specific tissues. Results of the in situ hybridization would lend insight into when and where we 
could expect a phenotype with plexinA1 knockdown. Additionally, it would help us begin to 
understand the interaction between these plexin receptors, if one exists. 
Interestingly, both plexinA1a and plexinA1b show mRNA expression even at very early 
developmental stages (Figure 12). These transcripts are expressed in the animal pole of the 
embryo as early as a half hour after the egg has been fertilized. Transcriptional and translational 
machinery is not yet active this early in development so the presence of these mRNAs indicates 
that they are maternally deposited in the egg. This means that they were made from the mother’s 
genome and then deposited into the oocyte (Abrams & Mullins, 2009). Many maternally 
deposited genes have important roles in initiation of critical early developmental events and it is 
possible that PLXNA1 may play an important role during these early stages. 
 
 
Figure 11. DNA products from PCR used to 
make antisense RNA probes (plexinA1b, right; 
plexinA1a, left).  Products shown on a 1% 
agarose gel with a 50 bp ladder.  













Figure 12. plexinA1a and plexinA1b are maternally deposited. Whole mount in situ hybridization of 
plexinA1a and plexinA1b at 0.5 (1-2 cell), 2 (64 cell), and 3.5 (1000 cell) hours past fertilization.  




When examined at the 8 somite (13 hpf) stage, plexinA1a and plexinA1b have already 
begun to show divergent expression patterns (Figure 12). While the transcripts for both are 
present in the anterior neural regions of head mesenchyme and presumptive brain tissue, 
plexinA1b is found in high concentration in the ventral domain of the early eye vesicle (Figure 
13D, E). This is very similar to the expression patterns of plexinA2 at this stage that have already 
been described (Figure 3) (Ebert et al., 2014). In contrast, plexinA1a is not seen in the eye vesicle 
at all (Figure 13A, B). Instead, it appears at the posterior midline of the head mesenchyme 
(Figure 13C, arrow). This suggests that PLXNA1a may be acting as a boundary cue for the early 
eye tissue.  
 To further investigate the potential roles of these two plexin receptors, we performed in 
situ staining on embryos up to 72 hpf. As previously discussed, the eye is essentially done 
developing and fully functional at this stage. plexinA1a has a diffuse neuronal expression early in 
development but is concentrated in the anterior neural regions of the embryo. Strong retinal 
expression is present from 24 hpf until 48 hpf (Figure 14A-C’) and is not present at later time 
points. The highest expression levels are seen in the medial periphery of the retina at 48 hpf 
(Figure 14C) which resembles the posterior midline expression pattern seen at 13 hpf (Figure 
13C). Expression levels are higher in the developing brain areas and at 72 hpf, concentrated 
expression is also seen in the lateral regions of the optic tectum (Figure 14E, E’). These patterns 
of expression suggest that plexinA1a is involved in patterning and formation of the eye.  
 plexinA1b also is expressed in diffuse neuronal regions at early developmental stages and 
its expression patterns seem to mirror plexinA1a (Figure 15A, B & Figure 14A, B). Interestingly, 
there is almost no expression seen in the retina after 36 hpf. At 60 and 72 hpf both plexins share 
a similar expression in the brain (Figure 14D, E & Figure 15D, E). plexinA1b appears to be  











Figure 13. mRNA expression of plexinA1a and plexinA1b at 13 hpf in (A, B, D & E) lateral wholemount 
and (C, F) and dorsal wholemount. (B, E) Blow-up of outlined section of A & D. Eye vesicle boundaries 
shown by dashed lines. Posterior midline expression shown by arrow. N=1, n=10. 
A B C 
F E D 










Figure 14. Developmental expression patterns of plexinA1a using in situ 
hybridization at 24, 36, 48, 60, and 72 hours post fertilization. N=1, n=10. 




localized to the optic tectum in particular but is more widespread in this region than plexinA1a 
(Figure 15D, E).  
This distinct but overlapping expression of these two plexins over time can be more 
clearly appreciated in a side-by-side comparison (Figure 16). At 48 hpf, only plexinA1a is 
present in the retina. At 72 hpf, the brain expression of each plexin receptor has become very 
specific although they do overlap in some regions. This difference in expression patterns 
between these two plexin homologs suggests that they play different roles in development but 
they may have compensatory or interacting functions in the tissues where they are co-expressed.  
  
 











Figure 15. Developmental expression patterns of plexinA1b using in situ hybridization 
at 24, 36, 48, 60, and 72 hours post fertilization. N=1, n=10. 





Figure 16.  Comparison of expression patterns of plexina1a and plexinA1b in the retina at 48 hpf and in the 
optic tectum at 72 hpf.  N=1, n=10. 




Functional role of plexinA1a and plexinA1b 
Unfortunately, after using multiple approaches, we were unable to find the N-terminal 
sequence for PLXNA1b in the genomic sequence of chromosome 23. Therefore, we pursued 
PLXNA1a only in further 
experimental paradigms. To 
assess a functional role for 
plexinA1a in the early visual 
system, antisense 
oligonucleotide morpholinos 
(MOs) were used to knock-down protein translation of plexinA1a (Figure 17). As previously 
mentioned, these MOs were designed to target a specific intron/exon boundary within the 
Ras/GAP domain of the mRNA, interfering with the correct splicing needed to make the final 
protein product. We expect that binding of this morpholino will create a truncated protein 
product. These MOs were injected at the one-cell stage into the rx3:GFP transgenic line, which 
expresses green fluorescence protein in the eye precursor cells (Rembold et al., 2006).  
Knocking down PLXNA1a caused significantly smaller early eye fields in morphants as 
compared to controls (student’s unpaired t-test, p<0.0001) (Figure 18). This phenotype was 
observed as early as the 10-12 somite stage (approximately 14-16 hpf). Additionally, the shape 
of the eye field was altered, resulting in a more rounded eye field that did not separate as well 
from the midline presumptive brain tissue as opposed to a well-defined, elongated elliptical field. 
This decrease in eye size of morphants as compared to controls was observed still at 5 days post 
fertilization (dpf) as well (student’s unpaired t-test, p<0.05, data not shown). Abnormal ectopic 
cells were also observed in 95% of morphant embryos (Figure 18B, arrows). In a separate  
Figure 17. Gene-specific 
antisense morpholinos 
(MOs) are injected into 
embryos at the one-cell stage 
to block translation and 
knock down gene function.  




































Figure 18. PLXNA1a is involved in early eye vesicle cohesion. Confocal imaging of (A) control and (B) 
plexinA1a morphant embryos at 18 hpf. Arrows indicate ectopic cells. (C) Quantification of eye area in 18 hpf 
control and morphant embryos (student’s unpaired t-test, p<0.0001). n= 20. 
C 
n= 20 n= 20 




experiment, the plexinA1a morpholino was also co-injected with a p53 MO at 4.0 nanograms and 
no difference in phenotype was seen, indicating that the morpholino was functioning as expected 
and not activating non-specific cell-death cascades (Robu et al., 2007) (Supplemental Data 
Figure 3). 
Morphant embryos were immunostained with a pHH3 antibody, which labels cells 
undergoing mitosis to observe proliferation in the early eye. Less staining was seen within the 
GFP+ eye field in morphants than controls indicating that there is a significant loss of 
proliferation. Eye area did not differ significantly in this case (student’s unpaired t-test, p >0.05) 
so the decrease in pHH3 labeling (student’s unpaired t-test, p<0.0001) cannot be accounted for 
by a decrease in total eye size (Figure 19).  
Under a bright field microscope, the morphants embryos show a lot of cell death 
(qualitatively observed by darkened tissue color) in the head region and some have significant 
developmental defects. Of those that survived the first few days, a few interesting non-eye 
phenotypes were observed. At 5 and 7 dpf, some morphant embryos exhibited cardiac edema or 
swelling of the heart, a curved body axis, and a protruding jaw (Supplemental Data Figure 4). 
These three phenotypes are similar to those seen for knockdowns of PLXNA2 and suggest that 
loss of PLXNA1a may have some widespread effects on general aspects of development. There 
were also a few observed cases of coloboma, in which the retina does not fully fuse around the 
lens. These are interesting to us because they may be related to initial defects in the formation of 
the optic cup as it migrated laterally from the midline.    
As a preliminary examination of the possible behavioral effects of loss of PLXNA1a, a 
tap test was done at 5 dpf. This measures the unconditioned startle reflex of the animals to a  
 













Figure 19.  Proliferation is decreased in plexinA1a morphant embryos. Confocal imaging of (A) control and (B) 
plexinA1a morphant embryos with pHH3 stain at 18 hpf. (C) No primary control. (D) Eye area is not different 
between morphants and controls (student’s unpaired t-test, p > 0.05). (E) Number of pHH3+ cells within the 
eye field is significantly smaller in morphants compared to controls (student’s unpaired t-test, p<0.0001).   
n=10 








stimulus. Normal fish will swim in short straight bursts at each application of the stimulus 
(Bailey, Oliveri, & Levin, 2013). During this test, plexinA1a morphants showed less movement  
in general and some individual fish exhibited difficulty with balance and motor coordination 
needed to initiate movement (data not shown). These deficits are likely not related to visual 
problems but they speak to the occurrence of general developmental abnormalities associated 
with these knockdown experiments.  
To assess the possible interaction of PLXNA1a and PLXNA2 in formation of the early 
eye, reduced concentrations of each morpholino that produced only a slight phenotype were 
individually injected. When these low-dose morpholinos were combined, a phenotype was seen 
similar in strength to that observed at the optimal dose for each morpholino, indicating a 
synergistic loss-of-function effect (Figure 20)(one-way ANOVA, F= 8.416, p<0.0001). Eyes in 
either single knockdown morphant groups were not significantly different from controls or from 
the opposite morphant group. The smallest eyes were seen in double morphants and were 
significantly different from controls at 18 hpf (student’s unpaired t-test, p<0.0001). Double 
morphants had significantly smaller eyes than the plexinA1a morphants (student’s unpaired t-
test, p<0.0001) but not the plexinA2 morphants (Figure 20E). This is likely a result of the 
increased dose sensitivity of the plexinA2 morpholino. 
Additionally, preliminary in situ data suggests that the knockdown of PLXNA2 
upregulates the mRNA expression of PLXNA1a and vice versa (Figure 21). This experiment was 
done under the same time frame for both control and morphant embryos in order to show more 
clearly the differences in staining. Therefore, it may not match the robust staining profile seen in 
previous experiments.  







Figure 20.  Eye size phenotype worse when PLXNA2 and PLXNA1a are knocked down. 
Confocal imaging of (A) control, (B) plexinA1a morphant, (C) plexinA2 morphant, and 
(D) plexinA1a/ A2 double morphant embryos at 18 hpf. (E) Double knockdown embryo 
eye fields show more ectopic cells and are smaller (one-way ANOVA, F= 8.416, 














































































Figure 21. in situ hybridization at 18 hpf of plexinA2 probe on UIC and plexinA1a morphant 
embryos and plexinA1a probe on UIC and plexinA2 morphant embryos.  




Chapter 4: Discussion 
 
Plexins are highly conserved across vertebrate species and have been implicated in many 
developmental neuronal processes. The interaction between semaphorins and plexins is well 
known in the context of axon guidance through growth cone remodeling in response to the local 
environment. A novel role of PLXNA2 and SEMA6A was recently discovered in the formation, 
cohesion and proliferation of the early eye. We predicted that due to their similar expression 
pattern to plexinA2 in the early eye and surrounding neuronal tissues that plexinA1a and 
plexinA1b may also be involved in these processes.  
The expression data we gathered suggested that the plexinA1a and plexinA1b receptors 
are not expressed in the same domains as plexinA2 during early eye development. While 
plexinA2 is concentrated in the ventral domain and surrounding head mesenchyme of the eye 
vesicle, plexinA1a is not found in the eye vesicle at all and is concentrated at the posterior 
midline in the bordering head mesenchyme. The current model suggests that PLXNA2 is acting 
as a repulsive cue within the ventral domain to direct cohesion and proliferation of the eye. It is 
possible that PLXNA1a is acting through a similar mechanism at the posterior boundary (Figure 
22). If both of these receptors interact with SEMA6A found on neuronal precursors migrating 
into the eye vesicle, they may be mediating the cohesion and patterning of the eye through this 
repulsion in overlapping regions. The downstream signaling molecules that are involved in this 
process is an ongoing avenue of investigation in the Ebert lab.  
 
 










Figure 22.  Comprehensive model of the mRNA expression patterns of plexinA1a, plexinA1b, and 
plexinA2 in the early eye vesicle (outline shown by dashed line). Inset shows location of eye vesicle (e) 
and brain tissue (br) in the 8 somite embryo. 




We discovered that there are two PLXNA1 genes in the zebrafish that encode extremely 
similar proteins and were likely replicates that arose during the evolution and duplication of the 
genome. However, it is interesting to note that their expression patterns are not identical, which 
indicates that their function may have diverged over time. Both plexinA1a and plexinA1b are 
expressed in the optic tectum at later developmental stages but in different domains. This 
differential expression patterns may be directing retinal ganglion cells within this brain region as 
they are migrating from the retina. Preliminary data also suggests that plexinA1b is present in the 
later developing eye where plexinA1a is absent. Again, this points to a potential separation of 
function for these two copies of PLXNA1.  
Additionally, we observed that plexinA1b is diffusely expressed in the early eye vesicle 
with a greater concentration at the ventral side. This expression pattern overlaps with plexinA2 in 
the ventral domain. The function of PLXNA1b warrants further exploration because it has such a 
similar expression pattern to PLXNA2 at early stages of eye development. It may also have a 
conserved function to PLXNA1a because they are so similar.  
The loss of cohesion and proliferation phenotype of the early eye seen originally in the 
plexinA2 morphants was also observed in the plexinA1a morphants, leading us to believe that 
these protein receptors are involved in the same or similar developmental mechanisms. This 
theory is further supported by the synergistic phenotypic profile of the double morphants as 
compared to single morphants. The mRNA up-regulation seen in the inverse in situ experiment 
suggests that they may function in a compensatory circuit, by which the expression of one plexin 
is directly or indirectly dependent on the other. When one becomes depleted or knocked down, 
the other will increase expression to compensate for the loss. This observed change in mRNA 
expression should be quantified with quantitative RT-PCR. Both plexin receptors must be active 




in a normal cellular environment though, or the individual phenotypes from the single 
knockdown experiments would not have been observed.  
While this evidence is compelling, it is still unclear as to the exact mechanism by which 
these two plexin receptors promote cohesion of the early eye. They may be activating the same 
intracellular cascades to cause the phenotype we observed. Microarray analysis of plexinA2 and 
sema6A morphants has identified 58 genes that change expression significantly in response to 
knockdown of either this plexin receptor or the specific semaphorin ligand (Ebert lab 
unpublished data).  These affected genes are likely to be mediating this phenotype within the 
downstream signaling cascades. It may be interesting to explore a second microarray between 
plexinA2 and plexinA1a to identify common molecules of interest and also determine whether 
they are both equally responsible for maintenance of cohesion.  
Further research is needed to determine whether PLXNA1a also binds the SEMA6A 
ligand as PLXNA2 does or whether it has a different signaling partner. Thus, investigation into 
the expression patterns of different semaphorins in the early eye may be helpful. Additionally, 
experiments looking into which specific boundaries of the eye vesicle are being affected by this 
loss of cohesion in the absence of one or more of the plexin receptors and whether this lines up 
with the in situ expression data would be very interesting and could lend further support to the 
model that is being developed.  
Finally, although they are useful tool for genetic manipulation, morpholinos can present 
issues such as off-target effects (Robu et al., 2007) so this research is being continued using other 
avenues of genetic mutant generation known as clustered regularly interspaced short palindromic 
repeats (CRISPRs) (Hwang et al., 2013). CRISPRs are a natural system of acquired immunity 




found in bacteria and archaea, similar to the RNA interference mechanism in eukaryotes (Koonin 
et al., 2009). They function in concert with Cas9 proteins, which function as endonucleases that 
degrade invading DNA. In recent years, they have been adapted for use as a specific genome-
editing tool to introduce mutations in genes of interest both in vitro and in vivo (Hruscha et al., 
2013; Hwang et al., 2013) (Figure 23). CRISPR technology allows us to perform site-directed 
mutagenesis to create specific point mutations in our gene of interest at the transcriptional level 
to create genetic mutants. These mutants will be immensely helpful in future research in cleaner 
experimentation procedures as the validity of morpholinos as research tools has recently been 
called into question (Kok et al., 2015).  
In conclusion, we have identified two plexin homologs, plexinA1a and plexinA1b, that 
share similar sequence homology to a previously investigated receptor, plexinA2. These three 
receptors share overlapping expression patterns in certain regions of the developing eye vesicle. 
Knockdown of either plexinA1a or plexinA2 results in disruption of cohesion and proliferation of 
the early eye, indicating that these two receptors are mediating a similar signaling pathway that 









Figure 23. CRISPR 
constructs complementary 
to a specific domain are 
injected into the one-cell 
embryo to create a double 
stranded DNA break. This 
break is repaired by non-
homologous end joining 
mechanisms resulting in a 
mosaic embryo (left). 
Injected embryos are raised 
to adulthood (founders), 
outcrossed to WT fish, 
screened to identify mutants 
and then incrossed to obtain 
stable mutant lines (left). 
Adapted from               
Huang et al., 2012. 
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Figure 1. Full alignment of PLXNA1a (top line), PLXNA11b (middle line), and PLXNA2 
(bottom line) including predicted sema, transmembrane, and RasGAP domains. 
Phosphorylation sites, acetylation sites, and ubiquitination sites are also identified. Primer 
binding sites and MO binding sites have also been highlighted. 
 
 























































































Figure 2. No probe control for in situ experiments.  




















Figure 3.Confocal image of (A) control, (B) plexinA1a MO, and (C) p53 MO/plexinA1a MO 
knockdown control at 18 hpf. 





Figure 4. Additional phenotypes observed 5 dpf following plexinA1a MO 
knockdown. (A) wild type. plexinA1a morphants have (B) cardiac edema, 
(C) coloboma, and (D) general eye and craniofacial disfigurement. 
